XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
128 hedge funds and large institutions have $1.05B invested in Acceleron Pharma in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
74% less call options, than puts
Call options by funds: $1.87M | Put options by funds: $7.33M
Holders
128
Holding in Top 10
3
Calls
$1.87M
Puts
$7.33M
Top Buyers
| 1 | +$16.2M | |
| 2 | +$14.5M | |
| 3 | +$10M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$9.88M |
| 5 |
Axa
Paris,
France
|
+$9.83M |
Top Sellers
| 1 | -$9.42M | |
| 2 | -$4.84M | |
| 3 | -$3.31M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.25M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.24M |